No Data
No Data
Morgan Stanley Maintains Regenxbio(RGNX.US) With Buy Rating, Raises Target Price to $24
BofA Securities Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $22
Stifel Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $40
REGENXBIO Earnings Call Highlights Strategic Progress
Express News | Chardan Capital Maintains Buy on Regenxbio, Maintains $52 Price Target
REGENXBIO Is Maintained at Overweight by Morgan Stanley